YU16403A - 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja - Google Patents
4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenjaInfo
- Publication number
- YU16403A YU16403A YU16403A YUP16403A YU16403A YU 16403 A YU16403 A YU 16403A YU 16403 A YU16403 A YU 16403A YU P16403 A YUP16403 A YU P16403A YU 16403 A YU16403 A YU 16403A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compounds
- production
- pharmaceutical compositions
- compositions containing
- halogenated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pronalazak se odnosi na 17-metilen steroide. Postupak za njihovu proizvodnju i farmaceutske sastave koji sadrže ova jedinjenja. Jedinjenja pronalaska imaju aktivni profil hibridnog karaktera takvog da se ponašaju kao inhibitori 5α-reduktaze i, u isto vreme, kao gestageni. Pomenuta jedinjenja su tako skrojena za lečenje medicinskih poremećaja koji su, kod muškaraca i žena, rezultat povećanog nivoa androgena u odredjenim organima i tkivima. Jedinjenja pronalaska kombinovana sa drugim hormonskim supstancama kao što su estrogen, testosteron ili potentni androgen su skrojena kao kontraceptivna sredstva za žene i muškarce.[The invention relates to 17-Methylene steroids. Method for the production thereof and pharmaceutical compositions containing these compounds. The inventive compounds have an active profile with a hybrid character of such that they act as inhibitors of the 5α-reductase and, at the same time, as gestagens. Said compounds are thus suited for treating medical disorders that, in men and women, are a result of an increased androgen level in certain organs and tissues. The inventive compounds combined with other hormonal substances such as estrogen, testosterone or a potent androgen are suited as contraceptives for women and men.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10043846A DE10043846A1 (de) | 2000-09-04 | 2000-09-04 | 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU16403A true YU16403A (sh) | 2006-05-25 |
| RS50305B RS50305B (sr) | 2009-09-08 |
Family
ID=7655148
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1423407B1 (sh) |
| JP (1) | JP2004513084A (sh) |
| KR (1) | KR100530816B1 (sh) |
| CN (1) | CN1262560C (sh) |
| AT (1) | ATE319733T1 (sh) |
| AU (2) | AU2002210470B2 (sh) |
| BG (1) | BG107594A (sh) |
| BR (1) | BR0113618A (sh) |
| CA (1) | CA2421302C (sh) |
| DE (2) | DE10043846A1 (sh) |
| DK (1) | DK1423407T3 (sh) |
| EA (1) | EA006387B1 (sh) |
| EE (1) | EE05186B1 (sh) |
| ES (1) | ES2260294T3 (sh) |
| HK (1) | HK1060135A1 (sh) |
| HR (1) | HRP20030256A2 (sh) |
| HU (1) | HUP0300936A3 (sh) |
| IL (2) | IL154666A0 (sh) |
| ME (1) | MEP14408A (sh) |
| MX (1) | MXPA03001912A (sh) |
| NO (1) | NO325012B1 (sh) |
| NZ (1) | NZ524485A (sh) |
| PL (1) | PL360669A1 (sh) |
| PT (1) | PT1423407E (sh) |
| RS (1) | RS50305B (sh) |
| SK (1) | SK286757B6 (sh) |
| UA (1) | UA74592C2 (sh) |
| WO (1) | WO2002019971A1 (sh) |
| ZA (1) | ZA200301715B (sh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10141984A1 (de) | 2001-08-28 | 2003-03-20 | Jenapharm Gmbh | Neue 17-Methylen-4-azasteroide |
| US7199115B2 (en) | 2004-04-19 | 2007-04-03 | Schering Ag | 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them |
| DE202007019049U1 (de) * | 2007-11-05 | 2010-05-12 | Bayer Schering Pharma Aktiengesellschaft | Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2611773A (en) * | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
| US3146239A (en) * | 1957-09-23 | 1964-08-25 | Syntex Corp | 4-halo-19-nor-progesterone |
| US3232960A (en) * | 1959-10-08 | 1966-02-01 | Upjohn Co | 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process |
| US3661940A (en) * | 1970-04-13 | 1972-05-09 | Sandoz Ag | Derivatives of 21-methyl-19-norpregnanes |
| US4389345A (en) * | 1981-10-09 | 1983-06-21 | G.D. Searle & Co. | 3-Oxoestra-17-acetonitrile and unsaturated analogs |
| US5994334A (en) * | 1997-02-05 | 1999-11-30 | University Of Maryland | Androgen synthesis inhibitors |
| AU2001268661A1 (en) * | 2000-06-27 | 2002-01-08 | Aventis Pharma S.A. | 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase |
-
2000
- 2000-09-04 DE DE10043846A patent/DE10043846A1/de not_active Ceased
-
2001
- 2001-08-29 PT PT01978315T patent/PT1423407E/pt unknown
- 2001-08-29 AU AU2002210470A patent/AU2002210470B2/en not_active Ceased
- 2001-08-29 DE DE50109175T patent/DE50109175D1/de not_active Expired - Lifetime
- 2001-08-29 JP JP2002524456A patent/JP2004513084A/ja active Pending
- 2001-08-29 MX MXPA03001912A patent/MXPA03001912A/es active IP Right Grant
- 2001-08-29 NZ NZ524485A patent/NZ524485A/en unknown
- 2001-08-29 EA EA200300322A patent/EA006387B1/ru not_active IP Right Cessation
- 2001-08-29 AU AU1047002A patent/AU1047002A/xx active Pending
- 2001-08-29 RS YUP-164/03A patent/RS50305B/sr unknown
- 2001-08-29 KR KR10-2003-7003170A patent/KR100530816B1/ko not_active IP Right Cessation
- 2001-08-29 UA UA2003042852A patent/UA74592C2/uk unknown
- 2001-08-29 DK DK01978315T patent/DK1423407T3/da active
- 2001-08-29 SK SK244-2003A patent/SK286757B6/sk not_active IP Right Cessation
- 2001-08-29 BR BR0113618-6A patent/BR0113618A/pt not_active IP Right Cessation
- 2001-08-29 CN CNB018151345A patent/CN1262560C/zh not_active Expired - Fee Related
- 2001-08-29 IL IL15466601A patent/IL154666A0/xx unknown
- 2001-08-29 WO PCT/EP2001/009943 patent/WO2002019971A1/de active IP Right Grant
- 2001-08-29 CA CA002421302A patent/CA2421302C/en not_active Expired - Fee Related
- 2001-08-29 ME MEP-144/08A patent/MEP14408A/xx unknown
- 2001-08-29 EP EP01978315A patent/EP1423407B1/de not_active Expired - Lifetime
- 2001-08-29 HU HU0300936A patent/HUP0300936A3/hu unknown
- 2001-08-29 AT AT01978315T patent/ATE319733T1/de not_active IP Right Cessation
- 2001-08-29 ES ES01978315T patent/ES2260294T3/es not_active Expired - Lifetime
- 2001-08-29 PL PL36066901A patent/PL360669A1/xx unknown
- 2001-08-29 EE EEP200300087A patent/EE05186B1/xx not_active IP Right Cessation
-
2003
- 2003-02-27 BG BG107594A patent/BG107594A/bg unknown
- 2003-02-27 IL IL154666A patent/IL154666A/en not_active IP Right Cessation
- 2003-02-28 ZA ZA200301715A patent/ZA200301715B/en unknown
- 2003-03-03 NO NO20030989A patent/NO325012B1/no not_active IP Right Cessation
- 2003-04-04 HR HR20030256A patent/HRP20030256A2/hr not_active Application Discontinuation
-
2004
- 2004-04-27 HK HK04102956A patent/HK1060135A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL149448A0 (en) | New topical estrogen-progestogen compositions with a systemic effect | |
| HUP0102483A2 (hu) | Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények | |
| MEP38008A (en) | Drospirenone for hormone replacement therapy | |
| MXPA03001859A (es) | Metodo para incrementar en la mujer testosterona y concentraciones de esteroides relacionados. | |
| DE60330695D1 (de) | Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate | |
| UA66861C2 (uk) | 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування | |
| WO2002019982A3 (en) | Cosmetic composition and method for reducing or preventing wrinkling | |
| SG154323A1 (en) | Estrogen replacement therapy | |
| ZA971965B (en) | Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination for the production of a pharmaceutical agent for treating a relative and absolute androgen deficiency in men. | |
| YU16403A (sh) | 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja | |
| MXPA05008347A (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis. | |
| AR048829A1 (es) | 17alfa - fluoroesteroides con actividad inhibidora de 5 alfa-reductasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades cancerosas influidas por androgenos. | |
| Whitehead | Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data | |
| WO2000067708A3 (en) | Oral steroidal hormone compositions and methods of use | |
| JO2334B1 (en) | Drospirenone for hormone replacement therapy |